{
  "main_header": {
    "sid": 338998,
    "name": "Gufic BioScience",
    "stock_name": "Gufic BioScience",
    "full_name": "Gufic BioSciences Ltd",
    "name_url": "stocks-analysis/gufic-bioscience",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "429.55",
    "chg": -2.35,
    "chgp": "-0.54%",
    "dir": -1,
    "prev_price": "431.90",
    "mcapval": "4,307.64 Cr",
    "mcap": "Small Cap",
    "scripcode": 509079,
    "symbol": "GUFICBIO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE742B01025",
    "curr_date": "Aug 11",
    "curr_time": "",
    "bse_nse_vol": "1.28 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 11, 2026",
    "traded_date_str": "2026 08 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/gufic-bioscience-338998-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Gufic BioSciences consolidated net profit rises 183.68% in the March 2026 quarter",
        "link": "https://news.google.com/rss/articles/CBMi-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?oc=5",
        "imagepath": "",
        "date": "2026-06-01 09:11:14",
        "description": "Gufic BioSciences consolidated net profit rises 183.68% in the March 2026 quarter  Business Standard..."
      }
    ],
    "total": 1,
    "sid": "338998",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/gufic-biosciences-338998"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "07-Aug-2026",
      "details": "Newspaper Advertisement - Notice of the 42nd Annual General Meeting of the Company is attached herewith",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
      "datetime": "31-Jul-2026",
      "details": "Intimation for Re-appointment of Mr. Pankaj Jayakumar Gandhi (DIN: 00001858) as the Whole Time Director of the Company is attached herewith.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Meeting Held On Friday July 31 2026",
      "datetime": "31-Jul-2026",
      "details": "Outcome of the Board of Directors Meeting held on Friday July 31 2026 is attached herewith",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Gufic BioSciences Ltd has declared <strong>10%</strong> dividend, ex-date: 22 Sep 25",
          "dt": "2025-09-22",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Gufic BioSciences consolidated net profit rises 183.68% in the March 2026 quarter

2026-06-01 09:11:14

Gufic BioSciences consolidated net profit rises 183.68% in the March 2026 quarter Business Standard...

Read More

View All News